Candida albicans is one of the most common opportunistic fungal pathogens, causing lifethreatening disease in immunocompromised patients. As it is not primarily a pathogen, but can exist in a commensal state, we aimed at the identification of new anti-infective compounds which do not eradicate the fungus, but primarily disable a virulence determinant. The yeast-hyphae-dimorphism of C. albicans is considered a major contributor to fungal disease, as mutants locked into either yeast or hyphal state have been shown to be less virulent in the mouse-model.
Introduction
With the progress in intensive medicine, fungal infections have become a serious public health problem, as advanced therapies of severe diseases are successfully applied, but render more patients with predisposing factors for fungal infections. These include a compromised immune status, central venous catheters, gastrointestinal surgery and extremes of age (Perlroth et al., 2007; Pfaller and Diekema, 2007) . The most common cause of invasive mycoses is the polymorphic yeast Candida albicans, an opportunistic pathogen which is found in its commensal state on the mucosa of the majority of the healthy population without causing disease symptoms. Systemic candidiasis, however, can be lethal and accounts for a mortality rate of 30-50 % (Tortorano et al., 2004; Wisplinghoff et al., 2004) . In addition, C. albicans can cause superficial infections, e.g. of the mucosa of mouth and vagina, which are not life-threatening but significantly reduce the quality of life.
In spite of the clinical application of four classes of antimycotics against systemic candidiasis, there have been continuous efforts to discover and develop new antimycotic compounds, as existing drugs may be associated with toxic side-effects or interactions with other therapeutics, high costs and resistance development (Gubbins and Amsden, 2005; Vermes et al., 2000) . Beside the screening for compounds with fungicidal or fungistatic activity and the description of novel potential antimycotic therapeutics (reviewed by Calugi et al. (2011) ), the recent years also saw the development of novel approaches to the search for antifungal agents (for example BurgerKentischer et al., 2011; Lafleur et al., 2011) .
One recent approach is the search for new lead compounds which attenuate virulence factors, the so-called pathoblockers. Resistance development to virulence-attenuating compounds should be rare, as the selective pressure on the population would not be as great, since avirulent subpopulations can survive (Jiang et al., 2002) . The yeast-hyphae-dimorphism is one of the most important and well-known virulence factors in C. albicans. Mutants locked into either the yeast or the filamentous morphology are avirulent in infection models (Lo et al., 1997; Murad et al., 2001b) .
The morphological change also influences other virulence factors, such as adhesion and biofilm formation. Moreover, yeast cells are more easily distributed in the bloodstream, and hyphae allow penetration of host tissue to access nutrient sources. The switch to hyphal growth can also help C. albicans to escape from phagosomes (Arai et al. 1977) .
Cultivation in rich media with a low pH at temperatures up to 30 °C favours growth as yeasts, whereas hyphal formation is triggered by nitrogen starvation, the presence of serum and 5 % CO 2 , and an increase of temperature to 37 °C and a neutral pH (Mitchell and Soll, 1979) .
Numerous signal transduction pathways control the switch between hyphae and yeast morphology.
Under yeast favouring conditions, the expression of hyphae-specific genes is controlled by a set of transcriptional repressors (Murad et al., 2001a (Murad et al., , 2001b . The cAMP-protein kinase A-pathway plays a central role in the induction of hyphae: the adenylate cyclase Cyr1p is activated by a number of stimuli, such as CO 2 -concentration, and signals from other proteins, e.g. the small G-protein Ras1p and the cytoskeleton (Fang and Wang, 2006; Klengel et al., 2005; Rocha et al., 2001; Zou et al., 2010) . Ras1p itself is activated in response to multiple signals, like nitrogen shortage or the presence of serum (Biswas and Morschhäuser, 2005; Feng et al, 1999) . The resulting increase in cAMP-concentration activates protein kinase A (Bockmühl et al., 2001 ), which in turn activates the transcription factor Efg1p to induce the expression of hyphae-specific genes, either alone or in interaction with further transcriptional activators (Lane et al., 2001; Schweizer et al., 2000; Stoldt et al., 1997) . Besides the cAMP-protein kinase A-pathway, MAP kinase-pathways are also involved in the induction of hyphae (Köhler and Fink, 1996; Leberer et al., 1996) . The MAP kinases Cek2p and, more importantly, Cek1p are activated via the MAP kinase kinase Hst7p and the MAP kinase kinase kinase Cst20p (Leberer et al., 1996; Csank et al., 1998) . Cst20p can be activated by Ras1p, like Cyr1p (Köhler and Fink, 1996) . The activation of these MAP kinases leads to the induction of hyphae-specific genes by the transcription factor Cph1p (Liu et al., 1994) . Extracellular pH is another important morphogenetic stimulus, and is signalled via the Rim-pathway. Rim101p is a transcription factor inhibiting expression of hyphae-specific genes. At neutral pH, a number of Rimproteins, as well as the ESCRT-complex, are recruited to the pH-sensor Rim20p (Xu and Mitchell, 2001 ). This triggers the proteolytic cleavage of Rim101p, turning Rim101p into an activator of hyphae-specific gene expression (Li et al., 2004) .
Amongst the hyphae specific genes is HWP1. It codes for the adhesin Hwp1p, which was detected in the cell wall of hyphae but never of blastoconidia. Likewise, the HWP1-transcript is only present after commitment to hyphal growth (Staab et al., 1996 (Staab et al., , 1999 .
We aimed for a potential high-throughput screening to find compounds which inhibit formation of hyphae in C. albicans. To this end, we made use of a reporter construct developed by Uhl and Johnson (2001) in which the promoter of HWP1 was fused to the gene for β-galactosidase from Streptococcus thermophilus. Hyphal induction of C. albicans CAI-4 transformed with this construct can be determined via measurement of the activity of β-galactosidase (Uhl and Johnson, 2001; Hogan et al., 2004) . By adapting the β-galactosidase assay to automated use in microtitre plate formats, we were able to identify three novel classes of antimycotic compounds in a pilot screening.
Materials and methods

Preparation of test compounds
All test compounds were dissolved in DMSO. MDL-12,330A (cis-N-2-(phenyl-cyclopentyl)-azacyclotridec-1-en-2-amine) was obtained from Sigma and a 5 mM stock solution was prepared.
Concentrations of stock solutions for farnesol (Sigma) were 1.1 mM and 1 g/l for the 720 novel synthetic compounds from EMC microcollections GmbH, Tübingen, Germany.
Strains and culture conditions
Candida albicans CAI-4 HWP1-lacZ (Hogan et al., 2004 ) was used in this study. Integration of lacZ upstream of the HWP1-promotor was confirmed by sequencing products of an uneven PCR executed according to the method of Chen and Wu (1996) . Cultures inoculated from a cryo-stock were grown overnight in a defined medium (containing 6.7 g/l yeast nitrogen base without amino acids, 9 g/l glucose and 1 g/l maltose) at 30 °C. Cells from the preculture were washed twice in prewarmed hyphal induction medium SLAD+ (1.7 g/l yeast nitrogen base without amino acids and without ammonium sulfate, 2 g/l glucose, 1 g/l maltose, 6 mg/l ammonium sulfate, buffered to pH 7.3 using 0.165 M MOPS) and afterwards resuspended in the same medium. The OD 620nm was adjusted to 0.05 to 0.1 as determined using a microtitre plate reader (µQuant, Biotek) in 180 µl sample volume (approx. 4-8*10 6 cells/ml). 50 µl of this suspension were added to each well of a 96-well plate. 1 µl of each test compound or DMSO as solvent-control were added.
The microtitre plate was incubated at 37 °C for 3h to induce hyphal growth.
Assay for β-galactosidase activity
After the induction of hyphal growth, C. albicans cells were lysed by the addition of 100 µl zbuffer, which was adapted from Kippert (1995) (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM Mg 2 SO 4 , 1 mM DTT, 0,2 % sodium lauroyl sarcosinate) to the C. albicans suspension in each well. Lysis was performed at 37 °C for 40 min.
Afterwards, 50 µl of 4 g/l ONPG (o-nitrophenyl-β-D-galactoside) in 0.1 M potassium phosphate buffer (pH 7.0) were added to each well. ONPG was hydrolysed by β-galactosidase during 90 min incubation at 37 °C. Optical densities at 414 nm and 550 nm were determined.
Data analysis
Calculation of β-galactosidase activity was adjusted from the calculation of Miller units (equation 1), which takes into account the absorption by o-nitrophenol produced from ONPG, the incubation time, the culture volume and OD 600 nm of the culture (Miller, 1972) . Between the assays on the same microtitre plate, the incubation time, starting volume and optical density were kept constant. Therefore, the absorption by o-nitrophenol (which we measured at the absorption maximum 414 nm) produced by hydrolysis of ONPG could serve as a measure of β-galactosidase activity. To eliminate the scatter by cell debris, Miller (1972) suggested an additional measurement at 550 nm, where o-nitrophenol absorption is low. He introduced a factor (designated c in eqn 1) to be multiplied with the OD 550 nm in order to approximate the contribution of the scatter by cell debris to the OD measured at 414 nm from the measurement at 550 nm. We experimentally determined c to be 1.36 when using microtitre plates instead of standard 1 cm-cuvettes our set-up. The absorption by o-nitrophenol was therefore calculated according to equation 1. 
High-throughput assay
The high-throughput assay was performed as described above, with all pipetting steps automated on an Evolution P 3 with Plate Stak (Perkin Elmer) automatic pipetting platform. In a pilot screening, 720 novel synthetic compounds from EMC microcollections GmbH at a final concentration of 20 mg/l (2 % DMSO) were tested. Measurements were performed on a microtitre plate reader (Fusion, Perkin Elmer) using filters centred around 425 nm and 550 nm. As some of the compounds had a strong yellow colour, the plates were also measured immediately after the addition of ONPG and these values were subtracted from the measurements after 90 min, according to equation 2 (with c being 1 in our plate reader). The ratio of this value to the mean of the negative controls (solvent controls) was calculated. The screening was repeated three times.
As a measure of assay quality control, the Z'-factor was calculated from the standard deviations The assay was performed as described above, but instead of a single concentration a dilution series of the test compound was added to in the induction medium. The assay was performed in half area plates (Corning) with culture volumes and the respective volumes of lysis buffer and ONPGsolution half as large as described above.
Susceptibility testing under yeast-favouring conditions
Growth inhibitory effects of antimycotic compounds on C. albicans yeast cells in liquid culture were determined in microtitre plates (180 µl volume). C. albicans was cultured over night in 50 ml YPD medium. A pre-culture was set up in YNB (6.7 g/l yeast nitrogen base, 20 g/l glucose) and 5000 cells/ml from an exponentially growing pre-culture were incubated in YNB at 30 °C with a dilution series of the compounds for 24 h and growth was determined photometrically by measuring the OD 620nm . Experiments were conducted in triplicate cultures.
Cytotoxicity
The human epithelial cell line A549 (Giard et al., 1973; Lieber et al., 1976) To determine the cytotoxicity of the novel compounds, 6000 cells per well were seeded in 96-well plates (180 µL) and incubated with dilution series of the compounds for 5 days at 37 °C and 5 % CO 2 . Final concentrations ranging from 0.01 to 60 mg/l were tested.
After 5 days, 500 mg/l MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide, from Sigma, dissolved in PBS at a stock concentration of 5 g/l) was added and incubation was continued for 2 h. The medium was discarded by inversion and the cells were washed once with 100 µl PBS, which was also discarded. 100 µl Isopropanol-HCl (0,4 % (v/v) 32 % HCl) were added to each well and incubated at room temperature for 20 min, before the absorption at 595 nm was measured. The ratios of these values to the corresponding values from a solvent control were calculated.
Experiments were performed in triplicate cultures.
Results
Establishment of β-galactosidase activity assay
As numerous environmental factors can induce and inhibit hyphal growth of C. albicans, we sought to establish well-defined culture conditions that would lead to reproducible outgrowth of germ tubes in our test strain. The inherent neutral pH and low nutrient availability of SLAD+ medium, as well as the elevated temperature (37 °C), constituted such conditions. In addition, SLAD+ is, in contrast to serum as an often used hyphal inductor, a defined medium and does not cause formation of froth, which is problematic in automated liquid handling. The medium was buffered so that the pH of the medium was not affected by acidic or basic test compounds.
Induction cultures were inoculated with C. albicans from the early stationary phase, as hyphal outgrowth could be efficiently induced in these cells (fig S1 A) . As the formation of hyphae is limited by cell density in C. albicans, we tested the effect of this factor on the HWP1-reporter assay.
Cell densities of 4-8 * 10 6 /ml achieved maximal rates of substrate turn-over (fig S1 B) .
The induction time of 3 h was chosen as HWP1 expression was high at this point in time (fig S1 C) and to ease optional microscopic inspection, as germ tubes were clearly visible after this time.
Reaction times for cell lysis and β-galactosidase reaction were chosen in accordance to previously published protocols (Kippert, 1995; Menzel, 1989; Miller, 1972) and to allow convenient handling time and parallel performance of large numbers of assays. The hydrolysis of ONPG in solvent controls remained proportional to the reaction time ( fig S1 D) , demonstrating that the reaction was not yet saturated after 1.5 h.
As low nitrogen availability was one of the hyphae-inducing factors in this assay, we wanted to exclude the possibility that test compounds could serve as nitrogen sources and, hence, influence the test result. Taking into account the molecular weights of the test substances, their potential nitrogen content and the test concentration of 20 mg/l, we added ammonium sulfate, a preferred nitrogen source of C. albicans, in concentrations up to 150 µM. We did not observe any changes in
HWP1-expression (fig S1 E).
The effects of known inhibitors of hyphae induction were tested to evaluate the assay's performance. MDL-12,330A is a specific inhibitor of adenylate cyclase Cyr1p. As Cyr1p is a central regulator of hyphae development in C. albicans, MDL-12,330A consequently inhibits hyphal growth (Sato et al., 2004) . Treatment of C. albicans HWP1-lacZ with 100 µM MDL-12,330A caused a significant reduction of hyphal growth, as was visible by microscopic analysis, as well as of β-galactosidase activity (fig 1 and fig S1 F ).
Validation of high-throughput assay
Likewise, the quorum sensing compound farnesol is a potent inhibitor of hyphal development (Hornby et al., 2001) . At a concentration of 22.5 µM, it inhibited nearly all germ tube formation and almost completely abolished β-galactosidase activity (fig 1) . Farnesol was used as positive control 8 to calculate the Z'-factor (Zhang et al., 1999 ; eqn 3) of the automated high-throughput assay.
C. albicans was incubated with 22.5 µM farnesol (positive control) or 2 % DMSO as solvent (negative) control as described using the liquid handling station. The results from 48 positive and 48 negative controls are shown in fig. 1 and the Z'-factor was calculated to be 0.78, which is indicates an excellent assay (according to Zhang et al., 1999) . The coefficient of variation for the negative (solvent) controls was 0.06.
Screening of 720 synthetic compounds and retesting
In a pilot screening campaign we tested 720 novel compounds, which were synthesised by EMC microcollections GmbH, in the automated HWP1-reporter assay at a final concentration of 20 mg/l. This concentration was chosen high to detect also weakly active compounds from among the as yet uncharacterised collection. We repeated the test three times with all compounds and performed a manual retest of those compounds, which reduced β-galactosidase activity by at least 90 % in all three screenings. We identified 10 compounds which reproducibly inhibited hyphal formation A range of concentrations of the identified compounds was tested for hyphae-inhibiting activity.
The IC 50 values for HWP1-expression as detected by the β-galactosidase assay were in the micromolar range (tab 1).
Inhibition of growth of C. albicans SC5314
As fungicidal and fungistatic compounds can also cause a decrease in HWP1-expression, the fungistatic potential of the hit compounds against C. albicans in yeast morphology was assessed.
The chosen test conditions reflected similarities to the hyphae-inducing conditions in the choice of medium base (yeast nitrogen base), but offered large amounts of nutrients (glucose and ammonium sulfate), an acidic pH and lower temperature to ensure yeast growth. Growth in the presence of a dilution series of the compounds was determined photometrically and the IC 50 -values are displayed in table 1. For most compounds, the critical concentrations for inhibition of HWP1-expression and yeast growth were similar or identical. Therefore, these compounds probably did not inhibit hyphal growth by specific inhibition of the respective signal transduction cascades.
However, compound 10 and -to a lesser extent -compound 8 inhibited germ tube formation at lower concentrations than yeast growth. 9
Cytotoxicity
As cytotoxicity against human cells is undesirable in potential therapeutics, the cytotoxicity of the hit compounds at different concentrations was determined in 5 d exposure tests using the human epithelial cell-line A549. Most compounds showed cytotoxic activity within the same concentration range as the antimicrobial activity, regardless of the chemical class of the compound. The compounds 2, 4, 7 and 8 were less toxic to human cells than to C. albicans (tab 1).
Discussion
Fungal infections are amongst the most common complications of intensive medicine and C. albicans is the most frequent fungal pathogen (Pfaller and Diekema, 2007; Tortorano, 2004) . In addition to severe illness, it can cause superficial infections of the mucosa which are very frequent.
Treatment of these infections relies on the availability of potent and safe anti-infectives. Drug discovery should exploit the continuous improvement of the understanding of the factors that lead to pathogenicity of this opportunistic fungus.
While a traditional approach to lead structure discovery was the screening of large libraries of compounds for fungistatic or fungicidal activity by detecting growth under in vitro conditions which did not take into account the understanding of the infection process, the recent years have seen the advent of new approaches. Especially with respect to opportunistic pathogens, the present understanding is that the mere presence of the microbe is not in itself harmful. Therefore the eradication of the microbe must not be the only way to treat an infection, but attenuators of virulence traits were searched (Jiang, 2002) . Thus, the development of novel tools for screening for compounds with therapeutic potential which target pathogenicity rather than viability is desirable.
We present here a novel screening assay, which makes use of a reporter strain to detect inhibitors of hyphal development. The morphological switch between yeast and hyphae is considered one of the most important virulence traits of C. albicans (Calderone and Fonzi, 2001) , and disabling this switch abolished virulence in infection models (Saville et al., 2006) . A number of chemically unrelated compounds are already known to inhibit the yeast-to-hyphae transition of C. albicans and the first applications of these compounds to infection models have been published, showing protective effects in models of mucosal infections (Akerey et al., 2009; Hisajima et al., 2008; Shareck and Belhumeur, 2011) . In our approach promotor activity of the hyphae-specific HWP1 gene is detected by means of a β-galactosidase assay. This approach is similar to a method described by Jarosz and Krom (2011) using a GFP-reporter assay. However, due to the greater sensitivity and robustness of the enzymatic assay, we could optimise our assay for automation and a higher throughput.
Optimised for automated liquid handling in miniaturised volumes, the assay presented here can be These classes of compounds were not yet known to inhibit fungal growth or influence fungal morphology. The active compounds with the lowest toxicity on mammalian epithelial cells (compounds 7 and 8) were aryl-oxazoline-carboxylates. An aryl-oxazoline-carboxylate was previously discovered as an antibacterial agent against Gram-positive species (Sasaki et al., 1997) .
To conclude, we show that this novel assay can be a valuable tool for the discovery of novel inhibitors of the yeast-hyphal switch, which could be developed as anti-infectives or whose mechanism of action will shed further light on the processes involved in yeast-to-hyphae transition. 
